|
NEK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.27720001031184E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46219999996866E-06 |
| Normal-vs-Stage2 |
2.239900E-03 |
| Normal-vs-Stage3 |
9.70270000011375E-07 |
| Normal-vs-Stage4 |
1.41170000000912E-06 |
| Stage1-vs-Stage2 |
5.344200E-01 |
| Stage1-vs-Stage3 |
2.827800E-02 |
| Stage1-vs-Stage4 |
7.595200E-04 |
| Stage2-vs-Stage3 |
3.805000E-01 |
| Stage2-vs-Stage4 |
6.604100E-03 |
| Stage3-vs-Stage4 |
2.225800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.00739999570254E-09 |
| Normal-vs-AfricanAmerican |
6.104400E-03 |
| Normal-vs-Asian |
1.359560E-01 |
| Caucasian-vs-AfricanAmerican |
7.789800E-02 |
| Caucasian-vs-Asian |
7.627000E-01 |
| AfricanAmerican-vs-Asian |
3.044800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.03799996270726E-09 |
| Normal-vs-Female |
1.51561999999217E-05 |
| Male-vs-Female |
2.018400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.321540E-02 |
| Normal-vs-Age(41-60Yrs) |
1.14799999995085E-06 |
| Normal-vs-Age(61-80Yrs) |
2.07360000281653E-08 |
| Normal-vs-Age(81-100Yrs) |
2.151700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.878360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.053200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.128100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.390400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.774200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.077400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.662620E-01 |
| Normal-vs-Grade 2 |
7.58050000000399E-05 |
| Normal-vs-Grade 3 |
4.23179999931023E-08 |
| Normal-vs-Grade 4 |
2.89730000002653E-06 |
| Grade 1-vs-Grade 2 |
1.736110E-03 |
| Grade 1-vs-Grade 3 |
1.01980000000168E-06 |
| Grade 1-vs-Grade 4 |
2.48099999999862E-05 |
| Grade 2-vs-Grade 3 |
3.780600E-03 |
| Grade 2-vs-Grade 4 |
5.180200E-04 |
| Grade 3-vs-Grade 4 |
6.484700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.036600E-04 |
| Normal-vs-ccB subtype |
1.21580000511656E-08 |
| ccA subtype-vs-ccB subtype |
9.60589999999817E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.79600000041569E-07 |
| Normal-vs-N1 |
2.082500E-03 |
| N0-vs-N1 |
1.245800E-02 |
|
|
